2000
DOI: 10.1016/s0196-0644(00)70055-2
|View full text |Cite
|
Sign up to set email alerts
|

Shorter duration of oral N -Acetylcysteine therapy for acute acetaminophen overdose

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
48
0
1

Year Published

2002
2002
2018
2018

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 92 publications
(49 citation statements)
references
References 18 publications
0
48
0
1
Order By: Relevance
“…The traditional treatment protocol for APAP poisoning in the USA consists of a 72-h course of oral N-acetylcysteine (NAC) [2][3][4]. More recently experts have recommended patient-tailored approaches to oral NAC treatment [5][6][7][8][9][10][11][12]. These protocols seek to truncate NAC therapy for patients showing evidence of recovery.…”
Section: Introductionmentioning
confidence: 99%
“…The traditional treatment protocol for APAP poisoning in the USA consists of a 72-h course of oral N-acetylcysteine (NAC) [2][3][4]. More recently experts have recommended patient-tailored approaches to oral NAC treatment [5][6][7][8][9][10][11][12]. These protocols seek to truncate NAC therapy for patients showing evidence of recovery.…”
Section: Introductionmentioning
confidence: 99%
“…8 It has been shown that the 20-hour and 48-hour IV NAC regimens and a 24-hour oral course are at least as effective as the standard 72-hour oral regimen in those who have not developed toxicity by the time the course has finished. 9,10 Therefore, it has become standard practice at our regional poison treatment center and others to discontinue treatment after one day if acetaminophen is undetected and aminotransferase levels are normal.…”
mentioning
confidence: 99%
“…10 Because the end of a 20-24-hour course will naturally be well past 24 hours postingestion, it is not surprising that discontinuation then, if the aminotransferase is normal, is effective. 9 In late presenters and for those with hepatic injury, short-course NAC is less effective. 1,10 This is likely due to a loss of the benefits of late NAC administration and discontinuation of NAC in the presence of progressing injury.…”
mentioning
confidence: 99%
“…The FDA approved a 72-h oral NAC regimen in 1985. However, evidence supports using shorter oral NAC courses provided that liver enzymes and synthetic function are normal or improving, and plasma APAP concentration is undetectable [1,2]. I n t r a v e n o u s N A C ( A c e t a d o t e ® , C u m b e r l a n d Pharmaceuticals) was approved by the FDA in 2004 and is indicated to prevent or lessen hepatic injury after potentially toxic APAP ingestion.…”
Section: Disclaimermentioning
confidence: 99%